Clinical Trials › NCT07139743
RecruitingPhase 1
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
Sponsored by Autolus Limited
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 18
Target enrollment
1
U.S. states
Aug 2025
Start date
Aug 2029
Expected completion
Interventions / Treatments
Obecabtagene autoleucel (obe-cel)
Conditions studied
Progressive Multiple Sclerosis
Where this trial is running (1 site)
California1 site
Redwood City
Participating MS centers on MS Buddy (1)
Stanford MS & Neuroimmunology Clinic
Palo Alto, CA
Palo Alto, CA
MS centers in California
Compare treatment centers near a trial site by center type, providers and trials.
View California centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.